DKNG stock · DMAC stock

DKNG vs DMAC · rev $4.77B vs $157.4M cap

DraftKings Inc (DKNG) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.

DraftKings Inc (DKNG) is a gambling company listed on US.

DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.

Latest reported DKNG revenue for 2024-12-31 was $4.77B. Net income was -$507.3M. Revenue was up 30.1% from 2023-12-31 to 2024-12-31. DKNG currently screens at market cap $20.96B.

DMAC does not have a complete income-statement cache yet.

DKNG currently screens at market cap $20.96B. DMAC currently screens at market cap $157.4M.

Not investment advice. Open the DKNG and DMAC stock pages for the full models.

Not investment advice.

Popular Stock Comparisons